The 60-second version of J.J. Finance Corporation Limited — what it does, how it earns, and who it competes with, before any of the numbers below.
What does this company do?
J.J. Finance Corporation Limited, a non-banking financial company, engages in the investment and other financing services in India. The company offers leasing and hire purchase, and finance services, as well as invests and deals in shares and securities.
IndustryCredit Services
SectorFinancial Services
Employees3
Annual revenue₹0 Cr
How does it make money?
Turns over ₹0 Cr a year. Of every ₹100 of sales, about ₹-11 reaches shareholders as profit, with ₹8 left at the operating level before interest, tax and depreciation. Each of its 3 employees supports ₹13.4 lakh of revenue a year, the signature of a people-led business.
Revenue / employee₹13.4 lakh
Who are its competitors?
The closest listed comparisons in its industry are BAJAJ FINANCE LIMITED, STATE BANK OF INDIA, HDFC BANK LTD, ICICI BANK LTD.. These are the companies its valuation and returns are measured against elsewhere in this report.
What is its competitive advantage?Not assessable from these ratios
For a lender, returns on capital are shaped by leverage and funding cost rather than by pricing power, so the usual financial signature of an advantage does not apply. Judge this one on deposit franchise, cost of funds and asset quality — none of which are in this data.
Peer median ROE16.5%
What has been driving growth?
Profit has moved mainly because margins changed, not because the business sold much more. Over 3 years revenue moved +1% while net margin moved -152% relative to itself. What this cannot tell you is which products, customers or geographies did the work — that lives in the segment disclosures of the annual report.
Revenue effect+1%
Margin effect-152%
DalalBaazaar Score
42/ 100
Moderate
Weighted across six categories. Every point is explained below.
✗ Return on equity is negative
Quality vs. Valuation
Company Quality
44/ 100
Weak
How good the business is, ignoring the share price entirely.
vs
Valuation
25/ 100
Expensive
What you are being asked to pay, ignoring how good the business is.
Weak on business quality and not cheap enough to compensate.
vs. its own history
Not enough price and earnings history
vs. sector peers
Not enough peers with a usable P/E
vs. generic bands
N/A
No P/E — the company is lossmaking
EV/EBITDA
531.2x
PEG
—
Red Flags
2 items require attention · 2 high
🔴The company is lossmakingFinancial
Net profit of -₹0 Cr in the latest reported year.
🔴Significant margin compressionFinancial
EBITDA margin has fallen 38.0 points, from 45.9% to 7.9%.
Investment Thesis
🟢 Bull CaseWhat could make this work?
No clear supporting case emerges from the available numbers.
🔴 Bear CaseWhat could go wrong?
Margins are being competed away
EBITDA margin has fallen from 45.9% to 7.9%. If the trend continues, profit falls even on flat sales — and margin decline rarely reverses quickly.
Growth barely outpaces inflation
Revenue compounding at 0.4% a year is close to the rate prices rise, so the business is gaining little ground in real terms. That leaves the share price dependent on a re-rating rather than on earnings growth.
Earnings are hard to forecast
Profit has swung sharply from year to year, so any single year — good or bad — is a weak guide to the next. Cyclical earnings deserve lower multiples for that reason.
Size brings its own risk
Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.
Several serious flags at once
2 high-severity checks triggered. Individually each has an explanation; together they raise the chance that something structural is wrong rather than a one-off.
🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today
1EBITDA margin holds above 6%✓ 7.9%
Two points below today's level — enough room for noise, tight enough to catch real compression.
2Return on equity stays above 8%✗ -0.4%
For a lender this is the cleanest single read on whether the book is being grown profitably.
3Revenue growth stays above 4% a year✗ 0.4% CAGR
Latest reported year was -90.0%. The bar is set below the established compounding rate, so ordinary variation does not trip it.
Investment Checklist
4 / 10 checks passed
✗ Strong return on equity (ROE ≥ 15%)
✗ Strong return on capital employed (ROCE ≥ 15%)
✗ Healthy net margin (≥ 10%)
✗ Generates positive free cash flow
✓ Adequate short-term liquidity (Current Ratio ≥ 1.0)
✗ Revenue growing year-over-year
✗ Profit growing year-over-year
✓ Not trading at an extreme valuation (P/E < 40x)
✓ Not buying right at the 52-week high
✓ Short-term technical trend isn't bearish
Price history
Quick Metrics
0 good · 4 neutral · 7 weak
Market Cap
₹17 Cr
Micro Cap
Smaller company — thin liquidity and deep drawdowns are normal here
P/E (Trailing)
Not meaningful
Loss-making
Earnings are negative, so a P/E multiple can't be read here
P/B Ratio
1.74x
Fair
Moderate premium to the company's book value
EPS (TTM)
₹-0.66
Loss-making
Negative earnings per share — the business is losing money
ROE
-0.4%
Weak
Weak capital efficiency
ROCE
0.3%
Weak
Low return on total capital employed
Debt/Equity
Not available
No data
Source didn't return this field
Revenue Growth (YoY)
-90.0%
Shrinking
Sales are contracting
Profit Growth (YoY)
-116.3%
Falling
Profits are shrinking
Dividend Yield
None
None
No dividend yield reported — usually means no payout, but verify if one was recently initiated
Free Cash Flow
-₹0 Cr
Cash burning
Spending more cash than the operations bring in
More Metrics
Operating Margin
-348.4%
Weak
Thin margins leave little room for error
Net Margin
-89.0%
Weak
Very little revenue reaches the bottom line
Current Ratio
896.90
Comfortable
Healthy short-term liquidity
Beta (vs Nifty)
-0.63
Defensive
Steadier than the market
52W Range Position
61%
Mid-range
Mid-range
Technical Snapshot
SMA 20 / SMA 50
51.5 / 49.1
Bullish alignment (short > long)
Price vs SMA 200
Above
Long-term uptrend
RSI (14)
92.5
Overbought zone
Financial Trend (4-Year)
Metric
FY23
FY24
FY25
FY26
3Y CAGR
Revenue
₹0 Cr
₹1 Cr
₹1 Cr
₹0 Cr
+0.4%
EBITDA
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
-44.3%
EBITDA Margin
45.9%
62.8%
57.3%
7.9%
—
PAT (Net Profit)
₹0 Cr
₹0 Cr
₹0 Cr
-₹0 Cr
—
EPS
₹0.29
₹1.3
₹0.93
₹-0.15
—
ROE
0.9%
3.8%
2.6%
-0.4%
—
ROCE
2.0%
5.0%
4.4%
0.3%
—
Free Cash Flow
-₹0 Cr
-₹0 Cr
-₹0 Cr
-₹0 Cr
—
🟡 Revenue has been broadly flat over 3 years (0.4% a year).
🔴 EBITDA has shrunk at 44.3% a year over 3 years.
🔴 EBITDA Margin has fallen from 45.9% to 7.9% over 3 years (-38.0 pts).
🔴 PAT (Net Profit) has turned negative, from ₹0 Cr to -₹0 Cr.
🔴 EPS has turned negative, from ₹0.29 to ₹-0.15.
🔴 ROE has fallen from 0.9% to -0.4% over 3 years (-1.4 pts).
🔴 ROCE has fallen from 2.0% to 0.3% over 3 years (-1.7 pts).
🟡Mixed / dependsA results event. The figures on this page update once the new statements reach the data feed, which usually lags the announcement.
Watch Items
Revenue growth is negative (-90.0%) on the latest reported period — check if this is one-off or a trend.
This is a financial-sector business: borrowing is its raw material, not leverage in the usual sense. Debt/Equity and ROCE here aren't comparable to a manufacturer's — read them alongside NIM, GNPA and capital adequacy from the company's own disclosures.
Cross-check against the company's latest quarterly filing / investor presentation before acting.
1 metric couldn't be retrieved for this stock — this is more common for smaller or thinly-covered listings.
RSI is in overbought territory — momentum entries here carry more short-term pullback risk.
Poor scores on business quality without a price low enough to compensate. There is no obvious argument for owning this over a stronger company at a similar valuation. 2 high-severity red flags sit above this conclusion and should be read first.
2 of 3 tripwires tripped — Return on equity stays above 8%; Revenue growth stays above 4% a year · see Key things to watch ↑